• Return to Headlines

Global Blood The Shares Up 26.6% Since SmarTrend's Buy Recommendation (GBT)

By James Quinn

SmarTrend identified an Uptrend for Global Blood The (NASDAQ:GBT) on January 11th, 2019 at $45.36. In approximately 3 months, Global Blood The has returned 26.63% as of today's recent price of $57.44.

Global Blood The share prices have moved between a 52-week high of $59.95 and a 52-week low of $30.15 and are now trading 91% above that low price at $57.50 per share. Over the past week, the 200-day moving average (MA) has gone up 0.6% while the 50-day MA has advanced 1.2%.

Global Blood Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on discovering, developing, and commercializing therapeutics to treat blood-based disorders. Global Blood Therapeutics serves customers worldwide.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Global Blood The shares.

Log in and add Global Blood The (GBT) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights global blood the

Ticker(s): GBT